TP53 and ovarian carcinoma: To determine whether our observation was specific to A2780 cells, we further treated 13 ovarian cancer cell lines (7 wild-type for p53 and 6 with missense or nonsense p53 mutations) with 2.5 μM cisplatin (Figure 2).